Tuesday, November 19, 2013

Prevention of breast cancer

Prevention of breast cancer
Cancer prevention is to take measures to reduce the opportunities for the development of cancerous condition . Using methods of prevention can reduce the number of new cases of cancer injuries within a population , which means reducing the number of deaths caused by cancer. To prevent the development of cancer cases seen scientists to the risk factors and protective factors . That any factor that increases the chance of developing cancer is called a risk factor for injury cancerous ; On the other hand any other factor contributing to the low chance of cancer called factor prevention of cancer incidence .
Factors have been linked with reduced chances of developing breast cancer :

    
Exercises: the practice of physical activity for more than 4 hours per week leads to a lower risk of breast cancer.
    
Early pregnancy : Women who have their first pregnancy before the age of 20 years reduced to have the proportion of breast cancer.
    
Breastfeeding : women who breastfeed their babies from the breast to have the highest chance stay Slemat and non-existent injury to have breast cancer .
Procedural interventions have risks has been linked with reduced chances of developing breast cancer :

    

    
Advantages: Based on the strong indications Tamoxavin the Tamoxifen and good indicators Raluxvin the raloxifene, an these medicines medicine reduces the risk of breast cancer in women after menopause. But that Altamoxavin reduced the risk of breast cancer in women who have a very high proportion of the risk before menopause . A Altamoxavin impact remains visible for several years after stopping treatment .
    
Risk : Altamoxavin therapy increases the risk of endometrial cancer , and increases the risk of clotting in the blood vessels ( lung clot , stroke , deep venous thrombosis ), and cataracts . Many of these risks , especially the lungs and clot deep venous thrombosis , down after stopping Altamoxavin . Based on the medical evidence good , Alraluxvin also increases the risk of stroke, lungs and deep venous thrombosis , but not associated with cancer of the lining of the uterus.
    
Enzyme inhibitors Eromatas [15] Aromatase inhibitors

    
Coenzyme Eromatas is the enzyme responsible for converting androgens to estrogens

    
Advantages: based on good evidence , the enzyme inhibitors Eromatas reduction of new cases of breast cancer in post- menopause in women who have had breast cancer.
    
Risk : Enzyme inhibitors Eromatas associated with decreasing bone mineral density , and low cognitive functions .
    
Preventive mastectomy [16]
    
Advantages: preventive removal of the breasts and reduces the risk of breast cancer in women with a family history of a huge injury or who have contracted cancer in one breast.
    
Risk : physical and psychological effects include anxiety, depression , and personal vibration , and a radical change in the external appearance of the chest area.
    
Preventive eradication ovaries [17] or ovarian ablation [18]
    
Advantages: Preventive eradicate the ovaries of women that suffer from a mutation in a gene BRCA -related injury breast cancer leads to lower incidence of cancer . Similarly eradication of ovarian ablation or strongly associated with a lower rate of breast cancer in ordinary women , who received treatment radial chest.
    
Risk : castration could cause the sudden onset of the symptoms of menopause such as hot flashes , insomnia , anxiety, and depression. And long - term effects include reduced sexual lust , vaginal dryness , and decreased bone mineral density .
    
Venritinaad Fenretinide
    
Advantages: taking Venritinaad medicine by mouth reduces the risk of postmenopausal breast cancer, new in women who previously contracted breast cancer [ 19 ] [20]
    
Risks : associated taking Venritinaad medicine , varying very bad for considering adaptation to darkness and skin changes , even with a 3 -day stop treatment per month . Therapy should be avoided during pregnancy to avoid potential abnormalities of the fetus.

No comments:

Post a Comment